Structure determination of human Lck unique and SH3 domains by nuclear magnetic resonance spectroscopy
© Briese and Willbold; licensee BioMed Central Ltd 2003
Received: 16 March 2003
Accepted: 7 May 2003
Published: 7 May 2003
Protein tyrosine kinases are involved in signal transduction pathways that regulate cell growth, differentiation, activation and transformation. Human lymphocyte specific kinase (Lck) is a 56 kDa protein involved in T-cell- and IL2-receptor signaling. Three-dimensional structures are known for SH3, SH2 and kinase domains of Lck as well as for other tyrosine kinases. No structure is known for the unique domain of any Src-type tyrosine kinase.
Lck(1–120) comprising unique and SH3 domains was structurally investigated by nuclear magnetic resonance spectroscopy. We found the unique domain, in contrast to the SH3 part, to have basically no defined structural elements. The solution structure of the SH3 part could be determined with very high precision. It does not show significant differences to Lck SH3 in the absence of the unique domain. Minor differences were observed to the X-ray structure of Lck SH3.
The unique domain of Lck does not contain any defined structure elements in the absence of ligands and membranes. Presence of the unique domain is not relevant to the three-dimensional structure of the Lck SH3 domain.
Protein tyrosine kinases are involved in signal transduction pathways that regulate cell growth, differentiation, activation and transformation. Human lymphocyte specific kinase (Lck) is a 56 kDa protein involved in T-cell- and IL2-receptor signaling. Lck is a typical member of the Src-type tyrosine kinase family and consists of four functional domains, namely unique, SH3, SH2 and kinase. Whereas amino acid sequences of the other domains are highly conserved among different kinases, those of the unique domains are not. Moreover, three-dimensional structures are known for SH3, SH2 and kinase domains of Lck [1–4] as well as for other tyrosine kinases. So far, however, no structure is known for the unique domain of any Src-type kinase. Lck unique domain is thought to serve as a membrane anchor, but also plays a role in function and specificity of the other domains, e.g. SH2 and SH3 . Further, Lck unique domain binds to the cytoplasmic regions of CD4 and CD8α via cysteines and a divalent cation [6, 7]. Because of its key role in T cell signaling and activation (for a review see ), it is not surprising that pathogenic factors like human immunodeficiency virus (HIV) and Herpesvirus saimiri have evolved effector molecules that target Lck to ensure their own replication and persistence. In particular, HIV-1 Nef and Herpesvirus saimiri Tip proteins directly bind to Lck SH3 domain. HIV-1 Nef also binds directly to CD4, which in turn binds directly to Lck unique domain. Thus, it is of interest to study the three-dimensional structure of Lck unique und SH3 domains as a whole, which is done in the present study by nuclear magnetic resonance (NMR) spectroscopy.
Constraints and structural statistics for the resulting 25 NMR structures of Lck(1–120)
Number of experimental restraints:
total number of assigned NOEs
intraresidual (|i-j| = 0)
interresidue sequential (|i-j| = 1)
interresidue medium range (1 < |i-j| 5)
long range (|i-j| > 5)
X-PLOR energies (kcal/mol)
234.7 ± 1.13
17.34 ± 0.27
88.15 ± 0.79
10.91 ± 0.53
56.01 ± 0.92
62.26 ± 0.88
RMS deviations to the mean structure (Å)
backbone heavy atoms
0.16 ± 0.04
all heavy atoms
0.67 ± 0.09
RMS deviations to experimental constraints and idealized geometry
0.0212 ± 0.0001
0.0031 ± 0
0.4183 ± 0.0019
0.2721 ± 0.0066
Φ, Ψ angles consistent with Ramachandran plot (%)
most favored regions
generously allowed regions
Large average local displacement values relative to the mean structure indicate either local flexibility of the protein or lack of experimental data for this region. Evaluation of these values for Lck SH3 solution structure indicate regions Leu69-Gly81, Gln93-Glu96, and Asn114Val116 of the protein to be less defined (Fig. 1C). The first two regions have also slightly decreased heteronuclear NOE values (Fig. 1B) indicating increased dynamic behavior of the residues therein. Those regions also show minor differences between the solution structure and the crystal structure (Fig. 2C). We deposited our data in the PDB under accession code 1KIK.
1H-15N-heteronuclear amide NOE values are a measure for the dynamics of the local environment within the time scale of the absolute nuclear magnetic resonance (NMR) frequencies (60 to 750 MHz in the present study). While negative 1H,15N-Hetero NOE values indicate flexible, unstructured regions, stabilizing structural elements give rise to values above 0.6 . As can be seen from figure 1B, residues of the unique domain show increased dynamic behavior. In addition, while a large number of medium- and long-range NOEs could be identified in the SH3 part of the molecule, only intraresidual or sequential NOEs were found for protons in the unique domain (fig. 1A). Our data clearly show that the complete unique domain is absent of any stable structural element. From our data, however, this can only be inferred for the absence of membranes or ligands. Whether the unique domain adopts a defined tertiary structure in the presence of Lck SH2 or kinase domains, a ligand, or when anchored in the membrane, remains to be determined.
In contrast to the unique domain, most residues of the SH3 domain show 1H,15N-heteronuclear amide NOE values larger than 0.6, indicating that this part of the molecule contains stable structural elements. Thus, only the SH3 part of the molecule was object to further evaluation of structural data. Together, 25 structures were obtained from simulated annealing molecular dynamics calculations based on experimental conformational restraint data. The obtained structures did not show any NOE distance violation greater than 0.2 Å. The root mean square deviation of these 25 structures relative to their average structure was 0.16 Å and 0.67 Å for backbone and all heavy atoms, respectively. That means, the resulting structure is rather well defined as seen in the overlay of all 25 protein backbone and side chain atoms (Fig. 2A).
The solution structure of Lck SH3 is very similar to the crystal structure of Lck SH3  (Fig. 2C). It exhibits a typical SH3 fold consisting of five antiparallel β-strands (βA: Leu65 to Ala68; βB: Gln87 to Glu92; βC: Trp92 to Ser102; βD: Glu108 to Pro112 and βE: Val116 to Lys118, Fig. 2B), that are forming two β-sheets packed at almost right angles, with strand βB participating in both sheets. A 310-helix formed by residues Phe113 to Phe115 was detected in two of 25 structures. This may suggest that the 310-helix frequently observed in crystal structures of SH3 domains is not necessarily present in all of the molecules in solution. It may, however, indicate as well that this is only due to lack of experimental data for this region (fig. 1A), leading to increased local displacement values (fig. 1B) despite high heteronuclear NOE values (fig. 1C) for residues around Phe115. Another NMR study on Lck SH3 that was published during the time course of the present study, also did not detect such a 310-helix .
The root mean square deviation (rmsd) value for the backbone coordinates of residues Asn64 to Asn120 is 1.05 Å between the hereby reported solution and the crystal  structure. The coordinates for the very carboxyl terminal residues, however, differ remarkably. Comparison with a previously reported solution structure of Lck SH3 domain  was not possible due to the lack of data deposition in the Brookhaven Protein Data Bank (PDB).
Employing recombinant human Lck comprising its unique and SH3 domains, we determined the solution structure of Lck SH3 with very high precision in the presence of Lck unique domain. We report for the first time structural aspects of a Src-type tyrosine kinase unique domain. In the absence of membranes or ligands, Lck unique domain does not contain any stable structural elements. Whether Lck unique domain adopts any defined structure in the presence of membranes or interaction partners like CD4 or CD8α, remains to be clarified by future investigations.
Expression and purification of residues 1 to 120 of human Lck comprising its unique and SH3 domains (LckU3) was carried out exactly as described earlier [9, 11]. Identity of the proteins was confirmed by MALDI-TOF-MS and N-terminal amino acid sequence analysis.
NMR samples contained 1.6 mM protein in 20 mM sodium acetate, 150 mM NaCl, pH 6.5, in 90 % H2O/10 % D2O with 10 mM 2-mercaptoethanol and 0.02 % (by weight) sodium azide. NMR spectra were recorded at 298 K on Varian Unity INOVA spectrometers equipped with a triple-axis pulse-field-gradient (PFG) 1H/15N/13C probe at proton frequencies of 600 and 750 MHz. The resonance assignment of LckU3 was previously described . Structural constraints were derived from 15N-edited NOESY-HSQC (100-ms mixing time)  and aliphatic 13C-edited NOESY-HSQC (80-ms mixing time) experiments  in the described buffer. Uniformly 13C-15N-labelled protein was used for these experiments. 15N-labelled protein was employed for the 1H-15N-heteronuclear NOE experiments .
Data evaluation and structure calculation
Based on the almost complete assignment of 1H, 13C, and 15N resonances of LckU3, a total of 1817 NOE distance constraints (including 610 long-range NOEs) could be derived from three-dimensional NOESY spectra in an iterative procedure (Table 1). NOE analysis and assignment was performed using XEASY  and ARIA . Interproton distances were used directly to calibrate experimental peaks and to extract distance constraints . Lower and upper bounds for distance constraints were derived from the target distances empirically by estimation of the error as 12.5% of the target distance squared. Distances involving ambiguous constraints, methyl groups, aromatic ring protons and the non-stereospecifically assigned methylene protons were treated as sum of separate contributions to the target function, known as "sum averaging" . Final structures were calculated using the simulated annealing protocol with CNS version 1.0  using standard parameters with the following modifications: For conformational space sampling 20 ps with a time step of 10 fs were simulated using torsion angle dynamics at a temperature of 50000 K, followed by 30 ps of slow cooling to 0 K with a time step of 15 fs. In an additional Cartesian slow cooling stage, the temperature was decreased for 20 ps from 2000 K to 0 K with a time step of 5 fs. After simulated annealing the structures were subjected to 2000 steps of energy minimization. A total of 25 structures that did not show any distance constraint violation of more than 0.2 Å was used for further analysis. Geometry of the structures, structural parameters and secondary structure elements were analyzed and visualized using the programs MOLMOL  and PROCHECK . The coordinates of the SH3 domain have been deposited in the Protein Data Bank, with accession code 1KIK.
List of abbreviations
lymphocyte specific kinase.
nuclear magnetic resonance.
Src homology domain 2.
Src homology domain 3.
nuclear Overhauser enhancement.
heteronuclear single quantum coherence.
Lck part comprising unique and SH3 domains.
Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) to D.W. (Wi 1472/4-1). We thank Drs. K.-H. Gührs and B. Schlott (Institut für Molekulare Biotechnologie, Jena) for carrying out mass spectroscopy and N-terminal amino acid sequencing.
- Eck MJ, Atwell SK, Shoelson SE, Harrison SC: Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature 1994, 368: 764–769. 10.1038/368764a0View ArticlePubMedGoogle Scholar
- Hiroaki H, Klaus W, Senn H: Determination of the solution structure of the SH3 domain of human p56 Lck tyrosine kinase. J Biomol NMR 1996, 8: 105–122.View ArticlePubMedGoogle Scholar
- Zhu X, Kim JL, Newcomb JR, Rose PE, Stover DR, Toledo LM, Zhao H, Morgenstern KA: Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure Fold Des 1999, 7: 651–661. 10.1016/S0969-2126(99)80086-0View ArticlePubMedGoogle Scholar
- Schweimer K, Hoffmann S, Bauer F, Friedrich U, Kardinal C, Feller SM, Biesinger B, Sticht H: Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck. Biochemistry 2002, 41: 5120–5130. 10.1021/bi015986jView ArticlePubMedGoogle Scholar
- Carrera AC, Paradis H, Borlado LR, Roberts TM, Martinez C: Lck unique domain influences Lck specificity and biological function. J Biol Chem 1995, 270: 3385–3391. 10.1074/jbc.270.7.3385View ArticlePubMedGoogle Scholar
- Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, Littman DR: Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990, 60: 755–765.View ArticlePubMedGoogle Scholar
- Huse M, Eck MJ, Harrison SC: A Zn2+ ion links the cytoplasmic tail of CD4 and the N-terminal region of Lck. J Biol Chem 1998, 273: 18729–18733. 10.1074/jbc.273.30.18729View ArticlePubMedGoogle Scholar
- Isakov N, Biesinger B: Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpesvirus saimiri and other viral gene products. Eur J Biochem 2000, 267: 3413–3421. 10.1046/j.1432-1327.2000.01412.xView ArticlePubMedGoogle Scholar
- Briese L, Hoffmann S, Friedrich U, Biesinger B, Willbold D: Sequence-specific 1H, 13C and 15N resonance assignments of lymphocyte specific kinase unique and SH3 domains. J Biomol NMR 2001, 19: 193–194. 10.1023/A:1008389229587View ArticlePubMedGoogle Scholar
- Kay LE, Torchia DA, Bax A: Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry 1989, 28: 8972–8979.View ArticlePubMedGoogle Scholar
- Preusser A, Briese L, Baur AS, Willbold D: Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain. J Virol 2001, 75: 3960–3964. 10.1128/JVI.75.8.3960-3964.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Zuiderweg ER, Nettesheim DG, Mollison KW, Carter GW: Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. Biochemistry 1989, 28: 172–185.View ArticlePubMedGoogle Scholar
- Muhandiram DR, Farrow NA, Xu G-Y, Smallcombe SH, Kay LE: A gradient 13C NOESY-HSQC experiment for recording NOESY spectra of 13C-labeled proteins dissolved in H2O. J Magn Res 1993, 102B: 317–321. 10.1006/jmrb.1993.1102View ArticleGoogle Scholar
- Farrow NA, Muhandiran R, Singer AU, Pascal SM, Kay CM, Gish G, Shoelson SE, Pawson T, Forman-Kay JD, Kay LE: Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 1994, 33: 5984–6003.View ArticlePubMedGoogle Scholar
- Bartels C, Xia T, Billeter M, Güntert P, Wüthrich K: The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J Biomol NMR 1995, 6: 1–10.View ArticlePubMedGoogle Scholar
- Linge JP, O'Donoghue SI, Nilges M: Assigning Ambiguous NOEs with ARIA. Meth Enzymol 2001, 339: 71–90.View ArticlePubMedGoogle Scholar
- Nilges M: A calculation strategy for the structure determination of symmetric dimers by 1H NMR. Proteins 1993, 17: 297–309.View ArticlePubMedGoogle Scholar
- Brünger AT, Adams PD, Clore GM, Delano WL, Gros P, Grosse-Kunstleve RW, J.-S. J, Kuszewski J, Nilges N, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL: Crystallography and NMR system (CNS): A new software system for macromolecular structure determination. Acta Cryst 1998, D54: 905–921.Google Scholar
- Koradi R, Billeter M, Wüthrich K: MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 1996, 14: 51–5. 10.1016/0263-7855(96)00009-4View ArticlePubMedGoogle Scholar
- Laskowski RA, Rullmann JAC, MacArthur MW, Kaptein R, Thornton JM: AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996, 8: 477–486.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.